YOOR BRIAN B 4
4 · ABBOTT LABORATORIES · Filed Aug 9, 2019
Insider Transaction Report
Form 4
YOOR BRIAN B
Senior Vice President and CFO
Transactions
- Exercise/Conversion
Common shares without par value
2019-08-08$34.94/sh+11,400$398,316→ 125,781 total - Sale
Common shares without par value
2019-08-08$85.77/sh−43,763$3,753,706→ 114,381 total - Exercise/Conversion
Option (right to buy)
2019-08-08−11,400→ 0 totalExercise: $34.94From: 2016-02-15Exp: 2023-02-14→ Common shares (11,400 underlying) - Exercise/Conversion
Common shares without par value
2019-08-08$39.12/sh+32,363$1,266,041→ 158,144 total - Exercise/Conversion
Option (right to buy)
2019-08-08−32,363→ 0 totalExercise: $39.12From: 2017-02-21Exp: 2024-02-20→ Common shares (32,363 underlying)
Holdings
- 2,222(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.50 to $86.21, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of August 8, 2019.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.